M. Pollak

First name
M.
Middle name
N.
Last name
Pollak
Azoulay, L., Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., & Suissa, S. (2012). The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. Bmj. http://doi.org/10.1136/bmj.e3645
View
Smiechowski, B., Azoulay, L., Yin, H., Pollak, M. N., & Suissa, S. (2013). The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-13-0196
View
Smiechowski, B. B., Azoulay, L., Yin, H., Pollak, M. N., & Suissa, S. (2013). The use of metformin and the incidence of lung cancer in patients with type 2 diabetes. Diabetes Care. http://doi.org/10.2337/dc12-0740
View
Assayag, J., Yin, H., Benayoun, S., Pollak, M. N., Suissa, S., & Azoulay, L. (2013). Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-012-0132-6
View
Bensimon, L., Yin, H., Suissa, S., Pollak, M. N., & Azoulay, L. (2014). Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-013-0334-6
View
Assayag, J., Pollak, M. N., & Azoulay, L. (2015). The use of aspirin and the risk of mortality in patients with prostate cancer. J Urol. http://doi.org/10.1016/j.juro.2014.11.018
View
Lian, Y., Yin, H., Pollak, M. N., Carrier, S., Platt, R. W., Suissa, S., & Azoulay, L. (2016). Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer. Eur Urol. http://doi.org/10.1016/j.eururo.2016.04.035
View
Hicks, B. M., Yin, H., Yu, O. H., Pollak, M. N., Platt, R. W., & Azoulay, L. (2016). Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink. Bmj. http://doi.org/10.1136/bmj.i5340
View
Abrahami, D., Yin, H., H. Y. Yu, O., Pollak, M. N., & Azoulay, L. (2018). Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000793
View